Evidence map›Paper›PMID 12789281›Full record

ReviewOncogene2003

Human melanocyte senescence and melanoma susceptibility genes.

Dorothy C Bennett

Abstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Melanoma therapeutics: a literature review.Journal of biomedical research · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. The effect of age on the acquisition and selection of cancer driver mutations in sun-exposed normal skin.Annals of oncology : official journal of the European Society for Medical Oncology · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. The miRNAs Role in Melanoma and in Its Resistance to Therapy.International journal of molecular sciences · 2020
    Review
  17. Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  18. Two-Step Senescence-Focused Cancer Therapies.Trends in cell biology · 2018
    Review
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Dorothy C BennettDepartment of Basic Medical Sciences, St George's Hospital Medical School, London SW17 0RE, UK. dbennett@sghms.ac.uk

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular mechanisms and biology of cellular senescence in human melanocytes are discussed, including similarities to and differences from senescence in fibroblasts and other cell lineages. Special reference is made to the fact that the known melanoma susceptibility genes in the human, Inhibitor A of [cyclin-dependent] kinase 4-alternative reading frame (INK4A-ARF) and cyclin-dependent kinase 4, are involved in the regulation of cellular senescence, and possible reasons why this should be so. Based on the evidence including growth and survival kinetics of human and mouse melanocytes carrying germline deficiencies in the INK4A sequence, it is suggested that an 'M0' or p16/RB-dependent form of senescence may be particularly important in melanocytes. A speculative model is proposed, relating current concepts of early melanoma progression to the processes of cellular senescence and immortalization. This includes the suggestion that moles or nevi are senescent clones of melanocytes.

Indexed as

Genetic Predisposition to DiseaseProto-Oncogene ProteinsAnimalsApoptosisCell Line, TransformedCells, CulturedCellular SenescenceCyclin-Dependent Kinase 4Cyclin-Dependent KinasesDisease ProgressionGenes, p16HumansMelanocytesMelanomaMiceRetinoblastoma ProteinCDK4 protein, humanCdk4 protein, mouseCyclin-Dependent Kinase 4Cyclin-Dependent KinasesProto-Oncogene ProteinsRetinoblastoma ProteinTumor Suppressor Protein p14ARF

Identifiers

PMID12789281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.